Abstract:As one of the central tasks of modern medicinal chemistry, scaffold hopping is expected to lead to the discovery of structural novel biological active compounds and broaden the chemical space of known active compounds. Here, we report the computational bioactivity fingerprint (CBFP) for easier scaffold hopping, where the predicted activities in multiple quantitative structure–activity relationship models are integrated to characterize the biological space of a molecule. In retrospective benchmarks, the CBFP representation shows outstanding scaffold hopping potential relative to other chemical descriptors. In the prospective validation for the discovery of novel inhibitors of poly [ADP-ribose] polymerase 1, 35 predicted compounds with diverse structures are tested, 25 of which show detectable growth-inhibitory activity; beyond this, the most potent (compound 6) has an IC<sub>50</sub> of 0.263 nM. These results support the use of CBFP representation as the bioactivity proxy of molecules to explore uncharted chemical space and discover novel compounds.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00234?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00234</a>.AMRR results for different screening datasets (Table S1 and Figure S1); PARP-1 inhibitors approved by FDA (Table S2); reverse target fishing of compound 6 and olaparib (Tables S3 and S4); information of the query data set (Table S5); the threshold of CBFP representation (Figure S2); workflow for CBFP construction (Figure S3) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00234/suppl_file/jm1c00234_si_001.pdf">PDF</a>).Molecular formula strings of all the compounds tested and associated biochemical data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00234/suppl_file/jm1c00234_si_002.xlsx">XLSX</a>).Information on the QSAR models of CBFP representation (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00234/suppl_file/jm1c00234_si_003.csv">CSV</a>).This article has not yet been cited by other publications.

Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges

On Scaffolds and Hopping in Medicinal Chemistry

DiffHopp: A Graph Diffusion Model for Novel Drug Design via Scaffold Hopping

Scaffold-Based Multi-Objective Drug Candidate Optimization

Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization

Scaffold Hopping and Optimization of Small Molecule Soluble Adenyl Cyclase Inhibitors Led by Free Energy Perturbation

Scaffold-Hopped Compound Identification by Ligand-Based Approaches with a Prospective Affinity Test

Scaffold-Induced Molecular Graph (SIMG): Effective Graph Sampling Methods for High-Throughput Computational Drug Discovery

Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation

Unveiling sultam in drug discovery: spotlight on the underexplored scaffold

Scaffold-Hopping Strategies in Aurone Optimization: A Comprehensive Review of Synthetic Procedures and Biological Activities of Nitrogen and Sulfur Analogues

Scaffold-based selective SHP2 inhibitors design using core hopping, molecular docking, biological evaluation and molecular simulation

Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer.

DeepScaffold: A Comprehensive Tool for Scaffold-Based De Novo Drug Discovery Using Deep Learning

Free energy perturbation (FEP)-guided scaffold hopping

Scaffold Hopping of Sampangine: Discovery of Potent Antifungal Lead Compound Against Aspergillus Fumigatus and Cryptococcus Neoformans.

Assessing the Scaffold Diversity of Screening Libraries

Molecular Scaffold Hopping via Holistic Molecular Representation

Scaffold overlay of flavonoid-inspired molecules: Discovery of 2,3-diaryl-pyridopyrimidin-4-imine/ones as dual hTopo-II and tubulin targeting anticancer agents

Scaffold Hopping Method for Design and Development of Potential Allosteric AKT Inhibitors

Computational Bioactivity Fingerprint Similarities To Navigate the Discovery of Novel Scaffolds